Showing results (31-40 of 64) with videos related to
Sort By:
Pageof 7
Pharmacology Research & Perspectives|May 13, 2021
Does atorvastatin therapy change the anti-Xa activity in xabans-treated patients with atrial fibrillation?Ingrid Škorňová, Matej Samoš, Tomáš Bolek, et al.Journal of Cardiovascular Pharmacology|June 26, 2021
Direct Oral Anticoagulants Plasma Levels in Patients with Atrial Fibrillation at the Time of Bleeding: A Pilot Prospective StudyIngrid Škorňová, Matej Samoš, Tomáš Bolek, et al.Journal of Medical Case Reports|February 3, 2024
Unilateral upper and lower limb ischemia mimics stroke: a case reportMonika Péčová, Jakub Benko, Martin Jozef Péč, et al.Journal of Cardiovascular Pharmacology|July 15, 2017
Platelet Aggregation in Direct Oral Factor Xa Inhibitors-treated Patients With Atrial Fibrillation: A Pilot StudyPeter Bánovčin, Ingrid Škorňová, Matej Samoš, et al.American Journal of Therapeutics|July 15, 2016
Does Pantoprazole Affect the On-Treatment Platelet Reactivity in Patients With Acute STEMI Treated With ADP Receptor Blockers?-A Pilot Prospective StudyTomáš Bolek, Matej Samoš, Radoslava Šimonová, et al.Journal of Cardiovascular Pharmacology|July 29, 2016
Heparin-induced Thrombocytopenia Presenting With Deep Venous Thrombosis and Pulmonary Embolism Successfully Treated With Rivaroxaban: Clinical Case Report and Review of Current ExperiencesMatej Samoš, Tomáš Bolek, Jela Ivanková, et al.Journal of Thrombosis and Thrombolysis|August 9, 2014
Monitoring of dabigatran therapy using Hemoclot(®) Thrombin Inhibitor assay in patients with atrial fibrillationMatej Samoš, Lucia Stančiaková, Jela Ivanková, et al.Journal of Thrombosis and Thrombolysis|October 6, 2018
Does proton pump inhibition change the on-treatment anti-Xa activity in xabans-treated patients with atrial fibrillation? A pilot studyTomáš Bolek, Matej Samoš, Ingrid Škorňová, et al.Frontiers in Cardiovascular Medicine|October 13, 2025
Right atrial and right ventricular strain in patients with acute decompensated heart failure: a pilot studyJakub Jurica, Martin Jozef Péč, Marek Cingel, et al.Journal of Clinical Medicine|December 11, 2022
Resistance on the Latest Oral and Intravenous P2Y12 ADP Receptor Blockers in Patients with Acute Coronary Syndromes: Fact or Myth?Peter Blaško, Matej Samoš, Tomáš Bolek, et al.Pageof 7